AKT1 and colorectal carcinoma: In this study, we demonstrated that NCOA5 upregulated p-AKT of CRC cells in a PI3K-dependent manner by Western blot and PI3K inhibitor assays, suggesting that NCOA5 is capable of augmenting PI3K/AKT activation in CRC cells.